Compound page for C00008 (ADP, ADP (from AMP), ADP (from ATP)): EzCatDB EzCatDB

Compound page for C00008: ADP, ADP (from AMP), ADP (from ATP)

Top page for Compound List

Formula: C10H15N5O10P2




Link to ChEBI
16761

Link to pubchem
6022

There are 90 entries for this compound.
  • M00114: 1.18.6.1 ; Nitrogenase molybdenum-iron protein alpha chain (Catalytic domain; 3.40.50.300, 3.40.50.1980)
  • M00199: 1.18.6.1 ; Nitrogenase molybdenum-iron protein alpha chain (Catalytic domain; 3.40.50.300, 3.40.50.1980)
  • M00210: 1.5.1.5, 3.5.4.9, 6.3.4.3 ; C-1-tetrahydrofolate synthase (Catalytic domain; 3.40.50.720, 3.40.192.10)
  • M00328: 2.7.10.1 ; ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase)AltName: CD_antigen=CD246; (Catalytic domain; 1.10.510.10)
  • M00325: 2.7.10.1 ; Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK)AltName: CD_antigen=CD202b; (Catalytic domain; 1.10.510.10)
  • M00124: 2.7.10.1 ; Ephrin type-B receptor 2 (Catalytic domain; 1.10.510.10)
  • M00127: 2.7.10.1 ; Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr)AltName: CD_antigen=CD331; (Catalytic domain; 1.10.510.10)
  • M00132: 2.7.10.1 ; High affinity nerve growth factor receptor (Catalytic domain; 1.10.510.10)
  • M00136: 2.7.10.1 ; Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor)AltName: CD_antigen=CD221; (Catalytic domain; 1.10.510.10)
  • M00129: 2.7.10.1 ; Insulin receptor (IR) (EC 2.7.10.1)AltName: CD_antigen=CD220; (Catalytic domain; 1.10.510.10)
  • M00330: 2.7.10.1 ; Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms)AltName: CD_antigen=CD115; (Catalytic domain; 1.10.510.10)
  • M00329: 2.7.10.1 ; Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron)AltName: CD_antigen=CD136; (Catalytic domain; 1.10.510.10)
  • M00323: 2.7.10.1 ; Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog)AltName: CD_antigen=CD117; (Catalytic domain; 1.10.510.10)
  • M00327: 2.7.10.1 ; Muscle (Catalytic domain; 1.10.510.10)
  • M00326: 2.7.10.1 ; Proto-oncogene tyrosine-protein kinase receptor Ret (Catalytic domain; 1.10.510.10)
  • M00331: 2.7.10.1 ; Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1)AltName: CD_antigen=CD135; (Catalytic domain; 1.10.510.10)
  • M00332: 2.7.10.1 ; Tyrosine-protein kinase Mer (Catalytic domain; 1.10.510.10)
  • M00131: 2.7.10.1 ; Vascular endothelial growth factor receptor 1 (Catalytic domain; 1.10.510.10)
  • M00335: 2.7.10.2, 2.7.11.1 ; Activated CDC42 kinase 1 (Catalytic domain; 1.10.510.10)
  • M00344: 2.7.10.2 ; Cytoplasmic tyrosine-protein kinase BMX (Catalytic domain; 1.10.510.10)
  • M00130: 2.7.10.2 ; Tyrosine-protein kinase ABL1 (Catalytic domain; 1.10.510.10)
  • M00304: 2.7.10.2 ; Tyrosine-protein kinase CSK (Catalytic domain; 1.10.510.10)
  • M00339: 2.7.10.2 ; Tyrosine-protein kinase Fes/Fps (Catalytic domain; 1.10.510.10)
  • T00256: 2.7.10.2 ; Tyrosine-protein kinase Fyn (Catalytic domain; )
  • M00148: 2.7.10.2 ; Tyrosine-protein kinase SYK (Catalytic domain; )
  • M00333: 2.7.10.2 ; Tyrosine-protein kinase ZAP-70 (Catalytic domain; 1.10.510.10)
  • T00255: 2.7.11.11 ; cAMP-dependent protein kinase catalytic subunit alpha (Catalytic domain; )
  • M00221: 2.7.11.13 ; Protein kinase C delta type (Catalytic domain; )
  • M00125: 2.7.11.15 ; Beta-adrenergic receptor kinase 1 (Catalytic domain; 1.10.510.10)
  • D00111: 2.7.1.11 ; 6-phosphofructokinase (Catalytic domain; 3.40.50.450, 3.40.50.460)
  • M00198: 2.7.11.19 ; Phosphorylase b kinase regulatory subunit alpha (Catalytic domain; 1.10.510.10, 3.30.200.20)
  • M00197: 2.7.11.1 ; Casein kinase II subunit alpha (Catalytic domain; 1.10.510.10, 3.30.200.20)
  • M00196: 2.7.11.22 ; Cyclin-dependent kinase 5 (Catalytic domain; 1.10.510.10, 3.30.200.20)
  • S00671: 2.7.1.12 ; Thermoresistant gluconokinase (Catalytic domain; 3.40.50.300)
  • T00224: 2.7.11.30 ; TGF-beta receptor type-1 (Catalytic domain; 1.10.510.10)
  • S00672: 2.7.1.145 ; Deoxynucleoside kinase (Catalytic domain; 3.40.50.300)
  • D00116: 2.7.1.149 ; Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (Catalytic domain; 3.30.800.10, 3.30.810.10)
  • M00043: 2.7.1.153 ; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Catalytic domain; 1.10.1070.11, 3.30.1010.10)
  • S00534: 2.7.1.15 ; Ribokinase (Catalytic domain; 3.40.1190.20)
  • S00541: 2.7.1.15 ; Ribokinase (Catalytic domain; 3.40.1190.20)
  • S00301: 2.7.1.19 ; Phosphoribulokinase 1 (Catalytic domain; 3.40.50.300)
  • D00416: 2.7.1.20 ; Adenosine kinase (Catalytic domain; 3.30.1110.10, 3.40.1190.20)
  • S00302: 2.7.1.21 ; Thymidine kinase (Catalytic domain; 3.40.50.300)
  • S00676: 2.7.1.24 ; Dephospho-CoA kinase (Catalytic domain; 3.40.50.300)
  • S00913: 2.7.1.24 ; Dephospho-CoA kinase (Catalytic domain; 3.40.50.300)
  • S00914: 2.7.1.24 ; Dephospho-CoA kinase (Catalytic domain; 3.40.50.300)
  • S00303: 2.7.1.25 ; Adenylyl-sulfate kinase (Catalytic domain; 3.40.50.300)
  • D00643: 2.7.1.2 ; Glucokinase (Catalytic domain; 3.40.367.20)
  • S00905: 2.7.1.35 ; Phosphomethylpyrimidine kinase (Catalytic domain; 3.40.1190.20)
  • S00678: 2.7.1.35 ; Pyridoxal kinase (Catalytic domain; 3.40.1190.20)
  • S00904: 2.7.1.35 ; Pyridoxamine kinase (Catalytic domain; 3.40.1190.20)
  • S00903: 2.7.1.35 ; Pyridoxine kinase (Catalytic domain; 3.40.1190.20)
  • T00043: 2.7.1.40 ; Pyruvate kinase I (Catalytic domain; 2.40.33.10, 3.20.20.60)
  • S00680: 2.7.1.48 ; Uridine-cytidine kinase 2 (Catalytic domain; 3.40.50.300)
  • S00705: 2.7.1.49, 2.7.4.7 ; Phosphomethylpyrimidine kinase (Catalytic domain; 3.40.1190.20)
  • S00453: 2.7.1.50 ; Hydroxyethylthiazole kinase (Catalytic domain; 3.40.1190.20)
  • S00554: 2.7.1.71 ; Shikimate kinase 1 (Catalytic domain; 3.40.50.300)
  • S00304: 2.7.1.71 ; Shikimate kinase 2 (Catalytic domain; 3.40.50.300)
  • S00555: 2.7.1.71 ; Shikimate kinase (Catalytic domain; 3.40.50.300)
  • T00239: 2.7.2.3, 5.3.1.1 ; Bifunctional PGK/TIM (Catalytic domain; 3.20.20.70, 3.40.50.1260, 3.40.50.1270)
  • D00127: 2.7.3.3 ; Arginine kinase (Catalytic domain; 3.30.590.10)
  • S00307: 2.7.4.10 ; GTP:AMP phosphotransferase mitochondrial (Catalytic domain; 3.40.50.300)
  • D00130: 2.7.4.13 ; Deoxynucleotide monophosphate kinase (Catalytic domain; 3.40.50.300)
  • S00308: 2.7.4.14 ; Cytidylate kinase (Catalytic domain; 3.40.50.300)
  • S00550: 2.7.4.14 ; Cytidylate kinase (Catalytic domain; 3.40.50.300)
  • S00305: 2.7.4.3 ; Adenylate kinase (Catalytic domain; 3.40.50.300)
  • S00547: 2.7.4.3 ; Adenylate kinase (Catalytic domain; 3.40.50.300)
  • S00548: 2.7.4.3 ; Adenylate kinase (Catalytic domain; 3.40.50.300)
  • D00129: 2.7.4.8 ; Guanylate kinase (Catalytic domain; 3.30.63.10, 3.40.50.300)
  • D00540: 2.7.4.8 ; Guanylate kinase (Catalytic domain; 3.30.63.10, 3.40.50.300)
  • S00306: 2.7.4.9 ; Thymidylate kinase (Catalytic domain; 3.40.50.300)
  • S00527: 2.7.4.9 ; Thymidylate kinase (Catalytic domain; 3.40.50.300)
  • M00186: 2.7.7.7, 3.1.11.1, 3.6.1.3 ; DNA polymerase III subunit alpha (Catalytic domain; 3.20.20.140, 3.30.420.10, 3.40.50.300, -.-.-.-)
  • S00268: 3.6.1.29 ; Bis(5''-adenosyl)-triphosphatase (Catalytic domain; 3.30.428.10)
  • M00102: 3.6.3.8 ; Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (Catalytic domain; 3.40.50.1000)
  • T00082: 4.1.1.21 ; N5-carboxyaminoimidazole ribonucleotide synthase (Catalytic domain; 3.30.470.20)
  • T00084: 4.1.1.49 ; Phosphoenolpyruvate carboxykinase {ATP} (Catalytic domain; 2.170.8.10, 3.40.449.10, 3.90.228.20)
  • M00137: 5.99.1.3 ; DNA gyrase subunit A (Catalytic domain; 3.90.199.10)
  • M00213: 5.99.1.3 ; DNA gyrase subunit B (Catalytic domain; 3.30.230.10, 3.30.565.10)
  • M00048: 5.99.1.3 ; DNA topoisomerase 2 (Catalytic domain; 3.30.230.10, 3.30.565.10, 3.40.50.670, 3.90.199.10)
  • D00452: 5.99.1.3 ; Type II DNA topoisomerase VI subunit A (Catalytic domain; 1.10.10.10)
  • D00516: 6.3.2.17 ; Folylpolyglutamate synthase (Catalytic domain; 3.40.1190.10)
  • M00051: 6.3.2.3 ; Glutathione synthetase (Catalytic domain; 1.10.1080.10, 3.30.470.20, 3.30.1490.50)
  • T00107: 6.3.2.3 ; Glutathione synthetase (Catalytic domain; 3.30.470.20, 3.30.1490.20)
  • T00108: 6.3.2.4 ; D-alanine--D-alanine ligase B (Catalytic domain; 3.30.470.20, 3.30.1490.20, 3.40.50.20)
  • D00298: 6.3.2.6 ; Phosphoribosylaminoimidazole-succinocarboxamide synthase (Catalytic domain; )
  • T00109: 6.3.2.9 ; UDP-N-acetylmuramoylalanine--D-glutamate ligase (Catalytic domain; 3.40.1190.10)
  • D00299: 6.3.3.1 ; Phosphoribosylformylglycinamidine cyclo-ligase (Catalytic domain; 3.30.1330.10, 3.90.650.10)
  • S00311: 6.3.3.3 ; Dethiobiotin synthetase (Catalytic domain; 3.40.50.300)
  • M00037: 6.3.4.13 ; Phosphoribosylamine--glycine ligase (Catalytic domain; )
    • Copyright: Nozomi Nagano, JST & CBRC-AIST
    Funded by PRESTO/Japan Science and Technology Agency (JST) (December 2001 - November 2004)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2005 - March 2006)
    Funded by Grant-in-Aid for Scientific Research (B)/Japan Society for the Promotion of Science (JSPS) (April 2005 - March 2008)
    Funded by BIRD/Japan Science and Technology Agency (JST) (September 2005 - September 2008)
    Funded by BIRD/Japan Science and Technology Agency (JST) (October 2007 - September 2010)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2011 - March 2012)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2012 - March 2013)
    Supported by the commission for the Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI) (October 2012 - )